Quantcast

Latest Clinical trial Stories

2014-06-06 23:01:25

Inspiring patient advocates collaborate with those who create and regulate therapies. Washington, DC (PRWEB) June 06, 2014 The 2014 DIA patient fellows illustrate the power of patient advocacy. A Parkinson’s disease patient is the driving force in the success of clinical trials, recruiting patients and transporting them to research sites while saving researchers thousands of dollars. A patient with a rare ailment that went undiagnosed for 40 years works hand in hand with researchers to...

2014-06-05 23:01:02

Leading research and industry experts discuss the role of researchers and the opportunities and challenges of a new monitoring model. Washington, DC (PRWEB) June 05, 2014 In a drug development landscape where clinical trial sponsors must find ways to gain value from limited research budgets, risk-based monitoring — the strategic assessment of risk when creating and conducting trials — is emerging as a model for reducing the complexity of a study while enhancing patient safety and...

2014-06-05 16:27:28

LONDON, June 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trials/post_menopausal_osteoporosis_global_clinical_trials_review_h1_2012.html Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, "Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2014"...

2014-06-05 16:27:21

LONDON, June 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/research_rd/clinical_trials/squamous_cell_carcinoma_global_clinical_trials_review.html Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, "Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Squamous...

2014-06-04 23:08:13

A new data standard for multiple sclerosis (MS) has been released by the Clinical Data Interchange Standards Consortium (CDISC), the leading global standards organization for clinical research. When used together with the foundational CDISC clinical data standard, this therapeutic area standard allows clinical research data from multiple MS trials to be grouped for reporting, analysis, and regulatory submissions. Austin, TX; New York, NY and Tucson, AZ (PRWEB) June 04, 2014 A new data...

2014-06-04 16:26:01

FDA Removes Clinical Hold on Phase 2 Trial (Study 202) SAN DIEGO, June 4, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold on patient enrollment and dosing of PEGPH20 in the ongoing Phase 2 trial (Study 202) evaluating PEGPH20 in patients with pancreatic cancer permitting the study to resume under a revised protocol. Patient enrollment is anticipated to recommence upon review...

2014-06-04 12:30:22

Congressman Fattah received an update on the transformative technological device that launched its clinical trials in his Philadelphia district and is now in trials at six VA hospitals around the country WASHINGTON, June 4, 2014 /PRNewswire-USNewswire/ -- In Washington last week, Congressman Fattah met with a United States Army veteran who was paralyzed from her waist down and is now successfully using ReWalk--a motorized exoskeleton suit--to stand and walk independently. The visit...

2014-06-04 12:29:56

BETHESDA, Md., June 4, 2014 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for cancer, announced today that Linda F. Powers, CEO, will present at the Jefferies 2014 Global Healthcare Conference, which is being held in New York. http://photos.prnewswire.com/prnvar/20110329/SF73084LOGO NW Bio's presentation will take place on Wednesday, June 4, at 2:00 p.m. EDT in Ballroom 5 at the...

2014-06-04 08:30:44

Raising Expectations of eClinical Solutions CLEVELAND, June 4, 2014 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified eClinical(®) technologies and delivering related services for the clinical trials industry, today announced their engagement at the upcoming DIA Trade Show in San Diego, CA from June 15 -19, 2014. "At DIA 2013, we introduced a transformational upgrade to the DATATRAK ONE(®) platform," said Laurence P. Birch, Chairman...

2014-06-04 08:30:14

SANTA ROSA, Calif., June 4, 2014 /PRNewswire/ -- Ruthigen, Inc., (NASDAQ: RTGN), a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics designed to prevent and treat infection in invasive applications, is pleased to announce the distribution of a letter from Hojabr Alimi, the Company's Chairman, Chief Executive Officer and Chief Science Officer, to its stockholders on Form 8-K on June 3, 2014. A download of the full PDF of this...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related